
Arthroplasty
3 doses of tranexamic acid more effective regimen in TKA
This report has been verified
by one or more authors of the
original publication.
Clin Orthop Relat Res. 2012 Sep;470(9):2605-12. doi: 10.1007/s11999-012-2310-y. Epub 2012 Mar 15.
206 patients undergoing total knee arthroplasty were randomized to 6 different groups to determine the ideal dosage and mode of treatment for tranexamic acid. Patients were to receive an intraoperative dose of tranexamic acid given before tourniquet deflation (group 1), an intraoperative dose of tranexamic acid with an additional preoperative dose (group 2), an intraoperative dose of tranexamic acid with an additional postoperative dose (group 3), a preoperative dose, intraoperative dose, and postoperative dose of tranexamic acid (group 4), a single local application of tranexamic acid (group 5), or no tranexamic acid (group 6). The results of the study indicated that a single-dose of tranexamic acid was not as effective as the multi-dose regimes. A double-dose was the lowest amount necessary to result in significant outcomes, and a triple-dose of tranexamic acid produced the most effective reduction in drain loss and total blood loss.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.